NovoCure Limited (NVCR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
26.83
0.60 (2.29%)
At close: Jan 15, 2025, 12:34 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Net Income | -207.04M | -92.53M | -58.35M | 19.81M | -7.23M | -63.56M | -61.66M | -131.84M | -111.58M | -80.68M | -77.37M |
Depreciation & Amortization | 10.97M | 10.62M | 10.25M | 9.15M | 8.46M | 9.01M | 7.68M | 5.65M | 3.15M | 1.96M | 1.22M |
Stock-Based Compensation | 115.61M | 106.95M | 94.90M | 75.72M | 52.42M | 39.85M | 27.12M | 22.14M | 11.86M | 4.62M | 5.12M |
Other Working Capital | -5.80M | -666.00K | -6.46M | -702.00K | -3.56M | 6.59M | 14.10M | 7.25M | 133.00K | 720.00K | 20.00K |
Other Non-Cash Items | -22.43M | -6.05M | 3.01M | 3.26M | -2.17M | 1.02M | 252.00K | 155.00K | 1.00M | -19.00K | 11.50M |
Deferred Income Tax | n/a | n/a | 3.88M | -270.00K | -519.00K | 407.00K | 241.00K | 5.75M | 46.00K | 23.00K | 19.00K |
Change in Working Capital | 29.56M | 11.80M | 29.07M | -8.52M | -24.33M | 11.41M | -6.76M | -9.44M | -4.36M | -152.00K | 6.80M |
Operating Cash Flow | -73.34M | 30.79M | 82.76M | 99.15M | 26.62M | -1.86M | -33.13M | -107.59M | -99.88M | -74.24M | -52.72M |
Capital Expenditures | -27.09M | -21.36M | -24.17M | -14.97M | -10.48M | -6.71M | -7.37M | -17.66M | -10.27M | -2.32M | -3.63M |
Acquisitions | n/a | 118.60M | 120.66M | 457.88M | 41.18M | 3.79M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.00B | -1.30B | -1.08B | -607.88M | -461.84M | -253.78M | -104.01M | -239.34M | -209.00M | -137.98M | n/a |
Sales Maturities Of Investments | 1.21B | 1.18B | 958.00M | 150.00M | 420.66M | 255.00M | 120.00M | 270.00M | 104.00M | 93.00M | 15.05M |
Other Investing Acitivies | n/a | -118.60M | -120.66M | -457.88M | -41.18M | -3.79M | -1.86M | -180.00K | -26.00K | 1.12M | -1.02M |
Investing Cash Flow | 184.15M | -139.96M | -144.83M | -472.85M | -51.67M | -5.49M | 6.77M | 12.81M | -115.30M | -46.18M | 10.40M |
Debt Repayment | -10.00K | -28.00K | -26.00K | 408.41M | -31.00K | 49.07M | -57.00K | 72.82M | 22.82M | -9.00K | -8.42M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.00K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 11.38M | 10.29M | 21.18M | 28.43M | 59.24M | 18.47M | 3.69M | 1.69M | 2.04M | 2.15M | 2.00K |
Financial Cash Flow | 15.79M | 15.49M | 25.70M | 440.21M | 61.68M | 69.37M | 5.17M | 75.12M | 276.99M | 2.15M | 183.32M |
Net Cash Flow | 126.73M | -93.78M | -36.56M | 66.76M | 36.66M | 62.04M | -21.19M | -19.64M | 61.81M | -118.28M | 141.00M |
Free Cash Flow | -100.43M | 9.43M | 58.59M | 84.18M | 16.14M | -8.58M | -40.50M | -125.26M | -110.16M | -76.56M | -56.34M |